ELEPSIA XR 1000 MG
levetiracetam
- Strength
- 1000 mg/1
- Form
- Tablet, Extended Release
TRIPOINT THERAPEUTICS, LLC
Levetiracetam
Listed by TAGI Pharma, Inc.
- Strength
- 100 mg/mL
- Form
- Injection, Solution, Concentrate
- Route
- Intravenous
What it contains
- Levetiracetam 100 mg/mL
FDA record
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Approval route | ANDA — approved generic |
| NDC code | 51224-013 |
| FDA application | ANDA209781 |
| RxNorm concept | 647121 |
| Marketed since | November 2018 |
Other products containing Levetiracetam
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
ELEPSIA XR 1500 MG
levetiracetam
- Strength
- 1500 mg/1
- Form
- Tablet, Extended Release
TRIPOINT THERAPEUTICS, LLC
Keppra
levetiracetam
- Strength
- 500 mg/1
- Form
- Tablet, Film Coated
UCB, Inc.
Keppra
levetiracetam
- Strength
- 100 mg/mL
- Form
- Solution
UCB, Inc.
Keppra
levetiracetam
- Strength
- 100 mg/mL
- Form
- Injection, Solution, Concentrate
UCB, Inc.
Keppra
levetiracetam
- Strength
- 1000 mg/1
- Form
- Tablet, Film Coated
UCB, Inc.
Keppra
levetiracetam
- Strength
- 250 mg/1
- Form
- Tablet, Film Coated
UCB, Inc.
Keppra
levetiracetam
- Strength
- 750 mg/1
- Form
- Tablet, Film Coated
UCB, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.